Post by R&D Partners

AI is rapidly changing oncology, but is technology alone enough to improve patient outcomes? The real breakthrough may come from combining AI with deep biological understanding. By integrating patient-derived data and multi-omics insights, researchers can better identify the right patients, reduce costly clinical trial failures, and make smarter drug development decisions earlier in the process. Precision oncology has long promised more targeted treatments. The question now is, how do we turn that promise into everyday practice? An interesting perspective on the future of oncology drug development: https://lnkd.in/en82SG3q What do you see as the biggest barrier to advancing precision oncology at scale? #PrecisionOncology #AI #Biotech #DrugDevelopment